Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Transmedics Group, Inc. (TMDX)  
$127.28 5.37 (4.05%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,915,000
Market Cap: 4.57(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $36.74 - $124.44
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,500 2,500
Total Buy Value $0 $0 $155,000 $155,000
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 271,054 342,899 405,806 1,060,395
Total Sell Value $27,491,657 $33,196,965 $37,923,912 $74,654,923
Total People Sold 4 6 6 10
Total Sell Transactions 21 30 40 119
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 350
  Page 2 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Corcoran Nicholas See Remarks   •       –      –    2024-02-23 4 A $0.00 $0 D/D 11,441 24,327     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-20 4 AS $90.00 $22,500 D/D (250) 14,375 44%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-20 4 OE $16.14 $4,035 D/D 250 14,625     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-16 4 AS $90.00 $257,220 D/D (2,858) 14,375 42%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-16 4 OE $16.00 $45,968 D/D 2,858 17,233     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-15 4 AS $90.00 $69,840 D/D (776) 14,375 43%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-15 4 OE $16.00 $12,416 D/D 776 15,151     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-14 4 AS $90.03 $274,592 D/D (3,050) 14,375 43%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-14 4 OE $16.00 $48,800 D/D 3,050 17,425     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-07 4 AS $90.09 $66,306 D/D (736) 14,375 45%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-02-07 4 OE $16.00 $11,776 D/D 736 15,111     -
   Basile Edward M   –       •      –    2024-02-06 4 AS $86.27 $618,209 D/D (7,157) 8,350 48%     
   Gordon Stephen Chief Financial Officer   •       –      –    2024-02-01 4 AS $85.45 $1,281,750 D/D (15,000) 13,075 45%     
   Gordon Stephen Chief Financial Officer   •       –      –    2024-02-01 4 OE $13.28 $273,151 D/D 15,000 28,075     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-01-23 4 AS $90.09 $209,910 D/D (2,330) 14,375 51%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-01-23 4 OE $16.00 $37,280 D/D 2,330 16,705     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-01-16 4 AS $80.40 $804,088 D/D (10,000) 14,375 61%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2024-01-16 4 OE $13.28 $132,800 D/D 10,000 24,375     -
   Gordon Stephen Chief Financial Officer   •       –      –    2024-01-02 4 AS $77.07 $1,156,050 D/D (15,000) 13,075 67%     
   Gordon Stephen Chief Financial Officer   •       –      –    2024-01-02 4 OE $13.28 $199,200 D/D 15,000 28,075     -
   Provost Miriam VP, Global Regulatory Affairs   •       –      –    2023-12-15 4 GD $0.00 $0 D/D 1,785 23,348     -
   Provost Miriam VP, Global Regulatory Affairs   •       –      –    2023-12-13 4 S $75.10 $309,562 D/D (4,122) 25,133 -17%     
   Provost Miriam VP, Global Regulatory Affairs   •       –      –    2023-12-13 4 OE $16.14 $252,914 D/D 5,644 27,540     -
   Hassanein Waleed H President & CEO   •       •      –    2023-12-01 4 AS $74.06 $558,033 D/D (7,500) 506,691 23%     
   Tobin James R   –       •      –    2023-11-28 4 S $70.14 $701,400 I/I (10,000) 233,591 -33%     
  350 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us